Abeona Therapeutics

Abeona Therapeutics, Inc.
Public
Traded as NASDAQ: ABEO
Industry Biomedicine
Founded Dallas, Texas 1989 (1989)
Headquarters United States
Website http://abeonatherapeutics.com/

Abeona Therapeutics, Inc. is a pharmaceutical development company. Its research focuses on developing treatments for rare diseases using gene therapy and human plasma-derived therapeutics. The company is trying to find ways to address Sanfilippo Syndrome, Fanconi anemia, and Juvenile Batten disease.[1] It has stated it anticipates starting clinical trials on an adeno-associated virus-based gene therapy for Sanfilippo syndrome in 2015.[2]

Abeona also is developing a salt diafiltration process for purifying proteins from blood plasma[3] and a polymer hydrogel for delivering drugs.

Name changes

The company was formerly known as Access Pharmaceuticals. It was based in Dallas and was incorporated in 1989.[4] In 2014, the company changed its name to PlasmaTech Biopharmaceuticals. In 2015, PlasmaTech acquired a company based in Cleveland called Abeona Therapeutics which was founded in 2013.[5] In June 2015, the parent company adopted the name Abeona Therapeutics.[6]

The name Abeona comes from a Roman goddess who was said to protect children.[7] The company's stock is traded on NASDAQ under the symbol ABEO.

References

  1. ↑ "Research & Development". Abeona Therapeutics. 2014-06-20. Retrieved 2015-09-20.
  2. ↑ PlasmaTech Biopharmaceuticals May 6, 2015 6:03 AM (2015-05-06). "PlasmaTech Biopharmaceuticals Announces Agreement to Acquire Abeona Therapeutics LLC - Yahoo Finance". Finance.yahoo.com. Retrieved 2015-09-20.
  3. ↑ "Abeona Therapeutics Provides Update on SDF(TM) (Salt Diafiltration) Plasma Fractionation Products". MarketWatch. 2015-07-07. Retrieved 2015-09-20.
  4. ↑ "ABEO - Company Profile for Abeona Therapeutics Inc - MSN Money". Msn.com. 2015-07-31. Retrieved 2015-09-20.
  5. ↑ "George Soros-backed PlasmaTech to acquire Cleveland's Abeona Therapeutics". Dallas Business Journal. 6 May 2015. Retrieved 21 September 2015.
  6. ↑ "PlasmaTech gets $8.5M infusion from investors George Soros, Perceptive Advisors, changes name to Abeona Therapeutics - Dallas Business Journal". Dallas Business Journal. 29 July 2015. Retrieved 21 September 2015.
  7. ↑ "Press Release | Investors | Abeona Therapeutics". Investors.abeonatherapeutics.com. 2014-06-20. Retrieved 2015-09-20.

External links

This article is issued from Wikipedia - version of the Wednesday, March 09, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.